A multi-centre randomized phase II study of nolatrexed versus doxorubicin in treatment of Chinese patients with advanced hepatocellular carcinoma
Tony S. K. Mok, Thomas W. T. Leung, Shou-Dong Lee, Yee Chao, Anthony T. C. Chan, Andrew Huang, Mei-Ching Lui, Winnie Yeo, Karen Chak, Amanda Johnston, Philip JohnsonТом:
44
Мова:
english
Сторінки:
5
DOI:
10.1007/s002800050982
Date:
August, 1999
Файл:
PDF, 79 KB
english, 1999